ABL Diagnostics (XPAR:ABLD) COGS-to-Revenue : 0.22 (As of Jun. 2023)

View and export this data going back to 1989. Start your Free Trial

What is ABL Diagnostics COGS-to-Revenue?

ABL Diagnostics's Cost of Goods Sold for the six months ended in Jun. 2023 was €0.65 Mil. Its Revenue for the six months ended in Jun. 2023 was €2.88 Mil.

ABL Diagnostics's COGS to Revenue for the six months ended in Jun. 2023 was 0.22.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. ABL Diagnostics's Gross Margin % for the six months ended in Jun. 2023 was 77.57%.

ABL Diagnostics COGS-to-Revenue Historical Data

The historical data trend for ABL Diagnostics's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ABL Diagnostics COGS-to-Revenue Chart

ABL Diagnostics Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

COGS-to-Revenue

Get a 7-Day Free Trial

0.83

0.05

ABL Diagnostics Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
COGS-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	0.22

ABL Diagnostics COGS-to-Revenue Calculation

ABL Diagnostics's COGS to Revenue for the fiscal year that ended in Dec. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.427	/	8.749
	=	0.05

ABL Diagnostics's COGS to Revenue for the quarter that ended in Jun. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.645	/	2.876
	=	0.22

ABL Diagnostics (XPAR:ABLD) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

ABL Diagnostics's Gross Margin % for the six months ended in Jun. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0.645 / 2.876
	=	77.57 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

ABL Diagnostics COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of ABL Diagnostics's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

ABL Diagnostics (XPAR:ABLD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » ABL Diagnostics (XPAR:ABLD) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

72c, rue de, WOIPPY, Thionville, FRA, 57140

Website

https://www.abldiagnostics.com

ABL Diagnostics is a diagnostic and medical software company. The group has focused on the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases. It also develops, manufactures, and markets kits for clinical specimen collection.

ABL Diagnostics (XPAR:ABLD) Headlines

No Headlines